查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1825870

2025年聚合酵素链锁反应（PCR）全球市场报告

Polymerase Chain Reaction (PCR) Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年聚合酵素链锁反应(PCR) 市场将强劲成长，到 2029 年将达到 182.7 亿美元，复合年增长率为 9.8%。预测期内的成长动力包括：日益增长的食品安全问题、对安全和高品质食品的需求不断增长、对分子诊断的需求不断增长、对个人化医疗的需求不断增长，以及对数位聚合酵素链锁反应(dPCR) 的日益关注。预测期内的主要趋势包括即时聚合酵素链锁反应(PCR)、DNA 定序技术、诊断检测的进步、次世代定序 (NGS)、微流体、实验室晶片平台以及先进分子诊断解决方案的开发。

预测的五年成长率为9.8%，较我们先前对该市场的预测略有下降0.8%。下降的主要原因是美国与其他国家之间的关税影响。贸易摩擦可能导致瑞士和韩国开发的即时聚合酵素链锁反应仪器和酵素试剂价格上涨，从而扰乱美国的诊断检测，导致疾病检测延迟和临床病理成本上升。由于互惠关税以及贸易紧张局势和限制加剧对全球经济和贸易的负面影响，贸易摩擦的影响也将更加广泛。

个人化医疗需求的不断增长预计将推动聚合酵素链锁反应(PCR) 市场的成长。个人化医疗，也称为精准医疗，涉及根据每位患者的个人特征量身定制医疗保健决策、实践、干预和治疗。由于数据分析的进步、患者独特的治疗反应以及根据个人基因图谱量身定制治疗的能力，对个人化医疗的需求正在增长。 PCR 透过扩增和分析特定基因序列在个人化医疗中发挥关键作用，使临床医生能够制定个人化的治疗计划。例如，根据美国专业会员组织个人化医疗联盟的数据，12 个个人化新药核准将占 2022 年所有新核准治疗方法的约 34%，比前几年大幅成长。因此，对个人化医疗日益增长的需求正在推动 PCR 市场的成长。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球聚合酵素链锁反应（PCR）：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素与限制因素）
  • 最终用途产业分析
  • 全球聚合酵素链锁反应（PCR）市场：成长率分析
  • 全球聚合酵素链锁反应(PCR) 市场表现：规模与成长，2019-2024 年
  • 全球聚合酵素链锁反应(PCR) 市场预测：规模与成长，2024-2029 年，2034 年
  • 全球聚合酵素链锁反应（PCR）：总目标市场（TAM）

第六章 市场细分

  • 全球聚合酵素链锁反应(PCR) 市场类型、表现及预测（2019-2024 年、2024-2029 年及 2034 年）
  • 常规聚合酵素链锁反应
  • 其他类型
  • 全球聚合酵素链锁反应(PCR) 市场：依适应症、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 感染疾病
  • 肿瘤学
  • 遗传性疾病
  • 其他适应症
  • 全球聚合酵素链锁反应(PCR) 市场：按应用、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 药品
  • 非医疗
  • 全球聚合酵素链锁反应(PCR) 市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 医院和诊所
  • 製药和生物技术产业
  • 诊断中心
  • 学术研究机构
  • 全球聚合酵素链锁反应(PCR) 市场：细分：常规聚合酵素链锁反应（按类型）、性能和预测，2019-2024 年、2024-2029 年、2034 年
  • 终点PCR
  • 凝胶电泳PCR
  • 逆转录PCR（Rt-PCR）
  • 基因表现定量PCR（QPCR）
  • 嵌套PCR
  • 全球聚合酵素链锁反应(PCR) 市场：按类型、实际和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 即时PCR（QPCR）（定量PCR）
  • 数位PCR（DPCR）
  • 多重PCR
  • 逆转录定量PCR（Rt-Qpcr）
  • 等温扩增（灯）
  • 下一代PCR（基于NGS的PCR技术）
  • 高通量PCR

第七章 区域和国家分析

  • 全球聚合酵素链锁反应(PCR) 市场：区域分析、预测与成长，2019-2024 年、2024-2029 年、2034 年
  • 全球聚合酵素链锁反应(PCR) 市场：依国家、表现及预测（2019-2024 年、2024-2029 年及 2034 年）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 聚合酵素链锁反应（PCR）市场：竞争格局
  • 聚合酵素链锁反应（PCR）市场：公司简介
    • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Becton, Dickinson and Company
  • GE HealthCare Technologies Inc
  • Laboratory Corporation of America Holdings（LabCorp）
  • Quest Diagnostics Incorporated
  • Eurofins Scientific
  • Agilent Technologies Inc.
  • Illumina Inc.
  • PerkinElmer Inc.
  • bioMerieux SA
  • Beckman Coulter Inc
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Qiagen NV
  • Natera Inc.
  • Myriad Genetics Inc.

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029年聚合酵素链锁反应（PCR）市场：提供新机会的国家
  • 2029年聚合酵素链锁反应（PCR）市场：细分领域带来新机会
  • 2029年聚合酵素链锁反应（PCR）市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r30969u

Polymerase chain reaction (PCR) is a laboratory technique employed to amplify specific segments of DNA. This process involves repeated cycles of heating and cooling to denature, anneal, and extend DNA strands, leading to the exponential amplification of the target sequence.

The main types of PCR are conventional polymerase chain reaction and other variants. Conventional PCR is used to amplify a specific DNA segment through repeated heating and cooling cycles. It is utilized in diagnosing various conditions such as infectious diseases, oncology, and genetic disorders. Its applications span both medical and non-medical fields, including hospitals and clinics, pharmaceutical and biotechnology industries, diagnostic centers, and academic and research organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The polymerase chain reaction (PCR) market research report is one of a series of new reports from The Business Research Company that provides polymerase chain reaction (PCR) market statistics, including polymerase chain reaction (PCR) industry global market size, regional shares, competitors with a polymerase chain reaction (PCR) market share, detailed polymerase chain reaction (PCR) market segments, market trends and opportunities, and any further data you may need to thrive in the polymerase chain reaction (PCR) industry. This polymerase chain reaction (PCR) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The polymerase chain reaction (pcr) market size has grown rapidly in recent years. It will grow from $11.42 billion in 2024 to $12.57 billion in 2025 at a compound annual growth rate (CAGR) of 10.1%. The growth in the historic period can be attributed to rising number of research facilities, increasing number of patients for chronic and infectious diseases, increasing prevalence of genetic and chronic disorders, increasing population, and growing geriatric population.

The polymerase chain reaction (pcr) market size is expected to see strong growth in the next few years. It will grow to $18.27 billion in 2029 at a compound annual growth rate (CAGR) of 9.8%. The growth in the forecast period can be attributed to the rising concerns over food safety, the increasing demand for safe and high-quality food products, the rising demand for molecular diagnostics, demand for personalized medicine, focus on digital polymerase chain reaction (dPCR). Major trends in the forecast period include real-time polymerase chain reaction, DNA sequencing technologies, diagnostic testing advancements, next-generation sequencing (NGS), microfluidics, lab-on-a-chip platforms, and advanced molecular diagnostic solutions development.

The forecast of 9.8% growth over the next five years reflects a modest reduction of 0.8% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. diagnostic testing by inflating prices of real-time Polymerase Chain Reaction instruments and enzymatic reagents developed in Switzerland and South Korea, resulting in delayed disease detection and higher clinical pathology costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising demand for personalized medicine is anticipated to drive the growth of the polymerase chain reaction (PCR) market. Personalized medicine, also known as precision medicine, involves tailoring healthcare decisions, practices, interventions, and treatments to the individual characteristics of each patient. The demand for personalized medicine is increasing due to advancements in data analytics, patient-specific treatment responses, and the ability to customize therapies based on individual genetic profiles. PCR plays a crucial role in personalized medicine by enabling the amplification and analysis of specific genetic sequences, allowing clinicians to create tailored treatment plans. For instance, according to the Personalized Medicine Coalition, a US-based professional membership organization, in 2022, the approval of 12 new personalized medicines accounted for approximately 34% of all newly approved therapies, indicating a significant increase from previous years. Thus, the growing demand for personalized medicine is fueling the growth of the PCR market.

Leading companies in the PCR market are developing real-time polymerase chain reaction (RT-PCR) test kits to improve the accuracy, efficiency, and ease of use in genetic analysis. RT-PCR is a laboratory-developed test that amplifies and quantifies specific DNA sequences in real time. For example, in November 2022, Cepheid, a US-based molecular diagnostics company, launched the Xpert Xpress Multiplex Vaginal Panel (MVP), an FDA-cleared multiplex PCR test that detects DNA from organisms associated with three distinct vaginal infections-bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoniasis-from a single vaginal swab sample. This test enhances traditional PCR methods by providing real-time monitoring, quantification, and increased sensitivity and specificity, making it a crucial tool in molecular biology and clinical diagnostics.

In April 2024, Bosch Healthcare Solutions GmbH, a Germany-based medical technology company, partnered with R-Biopharm AG for an undisclosed amount. The partnership aims to develop innovative PCR tests for multiresistant bacteria and strengthen their presence in the global clinical diagnostics market. R-Biopharm AG is a Germany-based biotechnology company specializing in clinical diagnostics.

Major companies operating in the polymerase chain reaction (PCR) market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers GmbH, Becton, Dickinson and Company, GE HealthCare Technologies Inc, Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., bioMerieux SA, Beckman Coulter Inc, Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Natera Inc., Myriad Genetics Inc., BGI Genomics Co. Ltd., Cepheid, NeoGenomics Laboratories Inc., 23andMe Holding Co., Ambry Genetics Corporation, Biocartis SA, Centogene N.V., Veritas Genetics

North America was the largest region in the polymerase chain reaction (PCR) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the polymerase chain reaction (PCR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the polymerase chain reaction (PCR) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The polymerase chain reaction (PCR) market consists of revenues earned by entities by providing services such as DNA amplification, gene expression analysis, pathogen detection, viral load quantification, reverse transcriptase enzyme, custom assay development, clinical diagnostics, gene cloning, genotyping and mutation detection, pathogen detection, technical support, training, and troubleshooting assistance to researchers and laboratory professionals using their products. The market value includes the value of related goods sold by the service provider or included within the service offering. The polymerase chain reaction (PCR) market also includes sales of thermal cyclers, quantitative polymerase chain reaction (qPCR) instruments, digital polymerase chain reaction systems, reverse transcription polymerase chain reaction (RT-PCR) kits, reagents and consumables, master mixes, nucleotides, centrifuges, primers, pipettes, polymerase chain reaction plates and tubes, polymerase chain reaction cleanup and purification kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Polymerase Chain Reaction (PCR) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on polymerase chain reaction (pcr) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for polymerase chain reaction (pcr) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The polymerase chain reaction (pcr) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Conventional Polymerase Chain Reaction; Other Types
  • 2) By Indication: Infectious Diseases; Oncology; Genetic Disorders; Other Indications
  • 3) By Application: Medical; Non-Medical
  • 4) By End User: Hospitals And Clinics; Pharmaceutical And Biotechnology Industries; Diagnostic Centers; Academic And Research Organization
  • Subsegments:
  • 1) By Conventional Polymerase Chain Reaction: Endpoint Pcr; Gel Electrophoresis-Based Pcr; Reverse Transcription Pcr (Rt-Pcr); Quantitative Pcr (Qpcr) For Gene Expression; Nested Pcr
  • 2) By Other Types: Real-Time Pcr (Qpcr) (Quantitative Pcr); Digital Pcr (Dpcr); Multiplex Pcr; Reverse Transcription-Quantitative Pcr (Rt-Qpcr); Isothermal Amplification (Lamp); Next-Generation Pcr (Ngs-Based Pcr Techniques); High-Throughput Pcr
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers GmbH; Becton, Dickinson and Company; GE HealthCare Technologies Inc; Laboratory Corporation of America Holdings (LabCorp); Quest Diagnostics Incorporated; Eurofins Scientific; Agilent Technologies Inc.; Illumina Inc.; PerkinElmer Inc.; bioMerieux SA; Beckman Coulter Inc; Sysmex Corporation; Bio-Rad Laboratories Inc.; Qiagen N.V.; Natera Inc.; Myriad Genetics Inc.; BGI Genomics Co. Ltd.; Cepheid; NeoGenomics Laboratories Inc.; 23andMe Holding Co.; Ambry Genetics Corporation; Biocartis SA; Centogene N.V.; Veritas Genetics
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Polymerase Chain Reaction (PCR) Market Characteristics

3. Polymerase Chain Reaction (PCR) Market Trends And Strategies

4. Polymerase Chain Reaction (PCR) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Polymerase Chain Reaction (PCR) Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Polymerase Chain Reaction (PCR) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Polymerase Chain Reaction (PCR) Market Growth Rate Analysis
  • 5.4. Global Polymerase Chain Reaction (PCR) Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Polymerase Chain Reaction (PCR) Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Polymerase Chain Reaction (PCR) Total Addressable Market (TAM)

6. Polymerase Chain Reaction (PCR) Market Segmentation

  • 6.1. Global Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Conventional Polymerase Chain Reaction
  • Other Types
  • 6.2. Global Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Infectious Diseases
  • Oncology
  • Genetic Disorders
  • Other Indications
  • 6.3. Global Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Medical
  • Non-Medical
  • 6.4. Global Polymerase Chain Reaction (PCR) Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals And Clinics
  • Pharmaceutical And Biotechnology Industries
  • Diagnostic Centers
  • Academic And Research Organization
  • 6.5. Global Polymerase Chain Reaction (PCR) Market, Sub-Segmentation Of Conventional Polymerase Chain Reaction, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Endpoint Pcr
  • Gel Electrophoresis-Based Pcr
  • Reverse Transcription Pcr (Rt-Pcr)
  • Quantitative Pcr (Qpcr) For Gene Expression
  • Nested Pcr
  • 6.6. Global Polymerase Chain Reaction (PCR) Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Real-Time Pcr (Qpcr) (Quantitative Pcr)
  • Digital Pcr (Dpcr)
  • Multiplex Pcr
  • Reverse Transcription-Quantitative Pcr (Rt-Qpcr)
  • Isothermal Amplification (Lamp)
  • Next-Generation Pcr (Ngs-Based Pcr Techniques)
  • High-Throughput Pcr

7. Polymerase Chain Reaction (PCR) Market Regional And Country Analysis

  • 7.1. Global Polymerase Chain Reaction (PCR) Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Polymerase Chain Reaction (PCR) Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Polymerase Chain Reaction (PCR) Market

  • 8.1. Asia-Pacific Polymerase Chain Reaction (PCR) Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Polymerase Chain Reaction (PCR) Market

  • 9.1. China Polymerase Chain Reaction (PCR) Market Overview
  • 9.2. China Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Polymerase Chain Reaction (PCR) Market

  • 10.1. India Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Polymerase Chain Reaction (PCR) Market

  • 11.1. Japan Polymerase Chain Reaction (PCR) Market Overview
  • 11.2. Japan Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Polymerase Chain Reaction (PCR) Market

  • 12.1. Australia Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Polymerase Chain Reaction (PCR) Market

  • 13.1. Indonesia Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Polymerase Chain Reaction (PCR) Market

  • 14.1. South Korea Polymerase Chain Reaction (PCR) Market Overview
  • 14.2. South Korea Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Polymerase Chain Reaction (PCR) Market

  • 15.1. Western Europe Polymerase Chain Reaction (PCR) Market Overview
  • 15.2. Western Europe Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Polymerase Chain Reaction (PCR) Market

  • 16.1. UK Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Polymerase Chain Reaction (PCR) Market

  • 17.1. Germany Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Polymerase Chain Reaction (PCR) Market

  • 18.1. France Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Polymerase Chain Reaction (PCR) Market

  • 19.1. Italy Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Polymerase Chain Reaction (PCR) Market

  • 20.1. Spain Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Polymerase Chain Reaction (PCR) Market

  • 21.1. Eastern Europe Polymerase Chain Reaction (PCR) Market Overview
  • 21.2. Eastern Europe Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Polymerase Chain Reaction (PCR) Market

  • 22.1. Russia Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Polymerase Chain Reaction (PCR) Market

  • 23.1. North America Polymerase Chain Reaction (PCR) Market Overview
  • 23.2. North America Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Polymerase Chain Reaction (PCR) Market

  • 24.1. USA Polymerase Chain Reaction (PCR) Market Overview
  • 24.2. USA Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Polymerase Chain Reaction (PCR) Market

  • 25.1. Canada Polymerase Chain Reaction (PCR) Market Overview
  • 25.2. Canada Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Polymerase Chain Reaction (PCR) Market

  • 26.1. South America Polymerase Chain Reaction (PCR) Market Overview
  • 26.2. South America Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Polymerase Chain Reaction (PCR) Market

  • 27.1. Brazil Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Polymerase Chain Reaction (PCR) Market

  • 28.1. Middle East Polymerase Chain Reaction (PCR) Market Overview
  • 28.2. Middle East Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Polymerase Chain Reaction (PCR) Market

  • 29.1. Africa Polymerase Chain Reaction (PCR) Market Overview
  • 29.2. Africa Polymerase Chain Reaction (PCR) Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Polymerase Chain Reaction (PCR) Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Polymerase Chain Reaction (PCR) Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Polymerase Chain Reaction (PCR) Market Competitive Landscape And Company Profiles

  • 30.1. Polymerase Chain Reaction (PCR) Market Competitive Landscape
  • 30.2. Polymerase Chain Reaction (PCR) Market Company Profiles
    • 30.2.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Polymerase Chain Reaction (PCR) Market Other Major And Innovative Companies

  • 31.1. Becton, Dickinson and Company
  • 31.2. GE HealthCare Technologies Inc
  • 31.3. Laboratory Corporation of America Holdings (LabCorp)
  • 31.4. Quest Diagnostics Incorporated
  • 31.5. Eurofins Scientific
  • 31.6. Agilent Technologies Inc.
  • 31.7. Illumina Inc.
  • 31.8. PerkinElmer Inc.
  • 31.9. bioMerieux SA
  • 31.10. Beckman Coulter Inc
  • 31.11. Sysmex Corporation
  • 31.12. Bio-Rad Laboratories Inc.
  • 31.13. Qiagen N.V.
  • 31.14. Natera Inc.
  • 31.15. Myriad Genetics Inc.

32. Global Polymerase Chain Reaction (PCR) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Polymerase Chain Reaction (PCR) Market

34. Recent Developments In The Polymerase Chain Reaction (PCR) Market

35. Polymerase Chain Reaction (PCR) Market High Potential Countries, Segments and Strategies

  • 35.1 Polymerase Chain Reaction (PCR) Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Polymerase Chain Reaction (PCR) Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Polymerase Chain Reaction (PCR) Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer